日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.

组蛋白甲基转移酶 KMT2D 是去势抵抗性前列腺癌谱系可塑性和治疗反应的关键介质。

Kittane Srushti, Ladewig Erik, Li Taibo, Love Jillian R, Blawski Ryan, Gao Yangzhenyu, Arruabarrena-Aristorena Amaia, Zhao Peihua, Dalrymple Susan L, Liu Huayang, Guo Xinyu, Sallaku Mirna, Kelkar Nachiket, Garcia-Martinez Liliana, Carmona Sanz Javier, Chen Wanlu, Stoudmann Candice, Baldino Laura, Razavi-Mohseni Milad, Kalemi Ingrid, Beer Michael A, Castel Pau, Brennen W Nathaniel, Scaltriti Maurizio, Morey Lluis, Cocco Emiliano, Ji Hongkai, Chan Ho Man, Battle Alexis, Leslie Christina S, Karthaus Wouter R, Toska Eneda

No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse

对于接受造血干细胞移植后急性髓系白血病复发并达到缓解的患者,细胞疗法巩固治疗并无明显益处

Murdock, H Moses; Kim, Haesook T; Maurer, Katie; Kelkar, Amar; Shapiro, Roman M; Gooptu, Mahasweta; Romee, Rizwan; Nageshwar, Prashant K; Garrity, Heather M; Shimony, Shai; Luskin, Marlise R; Winer, Eric S; Vedula, Rahul S; Stahl, Maximillian; Chen, Evan C; Volpe, Virginia; Garcia, Jacqueline S; Wadleigh, Martha; DeAngelo, Daniel J; Stone, Richard M; Wu, Catherine J; Cutler, Corey S; Koreth, John; Ritz, Jerome; Antin, Joseph H; Ho, Vincent T; Nikiforow, Sarah; Soiffer, Robert J

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML

对于预后不良的MDS/AML患者,先进行Venetoclax/FluBu2 RIC移植,随后进行全口服Venetoclax/地西他滨维持治疗。

Garcia, Jacqueline S; Kim, Haesook T; Murdock, H Moses; Bosch-Vilaseca, Anna; Panaro, Kevin M; Lim, Felicia; Fiorilla, Jade; Auriemma, Elise; Brock, Jennifer; Gooptu, Mahasweta; Ho, Vincent T; Cutler, Corey S; Shapiro, Roman; Kelkar, Amar H; Abel, Gregory A; DeAngelo, Daniel J; Stone, Richard M; Bat-Erdene, Denbaa; Ryan, Jeremy; Fell, Geoffrey; Letai, Anthony; Ritz, Jerome; Lindsley, R Coleman; Antin, Joseph H; Soiffer, Robert J

Lifetime Prevalence of Betel Nut Chewing in India and Taiwan: Raising Awareness of Oral Cancer Risks and the Urgent Call for Regulation

印度和台湾地区槟榔咀嚼终生患病率:提高公众对口腔癌风险的认识,并迫切呼吁加强监管

Rehman, Umar; Hudson, Helen; Hao, Chung-Yu; Ahn, Yuju; Kachole, Sanket; Liu, Jacklyn; Patel, Shruti; Xu, Mary Jue; Rouhani, Maral J; O'Flynn, Paul; Pethe, Vaijayanti; Hao, Sheng-Po; Kelkar, Dhananjay; Lechner, Matt

EGFR and AR expression and co-expression in Indian triple-negative breast cancer with patient outcome association

EGFR和AR在印度三阴性乳腺癌中的表达及共表达与患者预后的关系

Vaid, Pooja; Puntambekar, Anirudha; Kanse, Pranali; Kadu, Shweta; Agrawal, Piyush; Khatpe, Aditi; Banale, Rituja; Reddy, Ruhi; Kelkar, Devaki A; Hannenhalli, Sridhar; Shashidhara, L S; Koppiker, Chaitanyanand; Kulkarni, Madhura

Systemic Molecularly Targeted Therapies for Neoadjuvant and Salvage Craniopharyngioma: A Contemporary Narrative Review

新辅助和挽救性颅咽管瘤的系统性分子靶向治疗:当代叙述性综述

Neubecker, Joseph J; Griepp, Daniel W; Turnbull, Jeffrey P; Caskey, Joshua; Desai, Shivum; Mansour, Adam; Ahmed, Rabia; Beggs, Andrew; Griepp, Annie T K; Heitkotter, Heather; Claus, Chad F; Richards, Boyd F; Kelkar, Prashant S

Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau

神经元活动受损发生在Aβ1-42和突变型Tau蛋白聚集级联反应的早期阶段。

Hirsch, Franziska; F Läubli, Nino; Kelkar, Anushree; Sleiman, Mira; Woitzat, Yvonne; Gallrein, Christian; Gumz, Vanessa; Kalsi, Gurleen Kaur; Fernandez-Villegas, Ana; Schierle, Gabriele S Kaminski; Kirstein, Janine

Cyclooxygenase-2 (COX-2) as a Potential Prognostic Marker in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

环氧合酶-2 (COX-2) 作为口腔鳞状细胞癌潜在预后标志物:系统评价和荟萃分析

Qasem, Hanan M; Odat, Ramez M; Alshwayyat, Sakhr; Younis, Osama M; Yasin, Jehad A; Hussein, Ayham Mohammad; Hammadeh, Bara M; Ghlailat, Majed; Amayreh, Lujain Al; Yadav, Rukesh; Nguyen, Dang; Jain, Hritvik; Kelkar, Raveena

Drivers of Diagnostic Delay in Mitochondrial Disease: Missed Recognition of Canonical Features

线粒体疾病诊断延迟的驱动因素:未能识别典型特征

Tinker, Rory J; Jacob, Neil; Syed, Mohammad Ghouse; Kelkar, Janhawi; Donnelly, Colleen; Elsharkawi, Ibrahim; Ganesh, Jaya; Gelb, Bruce D; Pejaver, Vikas; Kozicz, Tamas; Morava, Eva

P-1422. Immunogenicity and Reactogenicity of Adjuvanted (Arexvy) and Non-Adjuvanted (Abrysvo) RSV Vaccines in Immunocompromised Individuals with Hematological Malignancies

P-1422. 佐剂(Arexvy)和非佐剂(Abrysvo)RSV疫苗在免疫功能低下且患有血液系统恶性肿瘤的个体中的免疫原性和反应原性

Olela, Ben; Mbaria, James; Wachira, Timothy; Moriasi, Gervason; Hannaford, Alisse; Izaguirre, Natalie E; Swank, Zoe; Van Haren, Simon D; Yates, Bridget; Kanwal, Urwah; Levine, Hannah; Tong, Alexandra; Shehata, Maria; Oladipupo, Fathia; Ryff, Kevin; Li, Xiaofang; Eustace, Aidan; Parisi, Lindsey; Hansen, Louise L; Sedney, Colleen J; Thomas, Sanya; Walt, David; Levy, Ofer; Kelkar, Amar H; Soiffer, Robert; Ho, Vincent; Lan, Zhou; Baden, Lindsey R; Issa, Nicolas C; Woolley, Ann E; Sherman, Amy C